| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | microtubule binding | EML6 TUBGCP4 S100A9 ALMS1 MTUS1 STARD9 DNM1 DNM2 KIF13B KIF20B VPS41 DNM3 CEP295 KIF13A | 1.93e-05 | 308 | 236 | 14 | GO:0008017 |
| GeneOntologyMolecularFunction | ABC-type polyamine transporter activity | 1.39e-04 | 2 | 236 | 2 | GO:0015417 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.78e-04 | 70 | 236 | 6 | GO:0003777 | |
| GeneOntologyMolecularFunction | tubulin binding | EML6 TUBGCP4 S100A9 ALMS1 MTUS1 STARD9 DNM1 DNM2 KIF13B KIF20B VPS41 DNM3 CEP295 KIF13A FYN | 1.86e-04 | 428 | 236 | 15 | GO:0015631 |
| GeneOntologyMolecularFunction | serine-type endopeptidase inhibitor activity | 2.51e-04 | 105 | 236 | 7 | GO:0004867 | |
| GeneOntologyBiologicalProcess | neuron projection development | EPHB2 MAG DLG5 RELN RAP1GAP2 SPART TSHR ITGA1 ADGRV1 PTK2 S100A9 SERPINI1 ALMS1 PTPRG P3H1 SCN1B CNTN5 VPS13A ADAM17 DNM2 KIF13B EVL CACNA1F NRDC DSCAM KALRN TNC NR4A3 FRYL VPS54 INPP5F ATP9A KIF20B CELSR2 ZNF335 CAPRIN2 DNM3 FYN EPHA3 EPHA5 | 6.83e-09 | 1285 | 236 | 40 | GO:0031175 |
| GeneOntologyBiologicalProcess | cell morphogenesis | EPHB2 MAG RELN SPART ITGA1 GRHL2 ITGB6 PTK2 TUBB1 HEG1 SCN1B CNTN5 VPS13A AHR ADAM17 DNM2 KIF13B EVL CACNA1F NRDC DSCAM KALRN ARHGEF18 NR4A3 FRYL VPS54 CFAP43 ATP9A KIF20B SIDT2 CELSR2 ZNF335 CAPRIN2 DNM3 FYN EPHA3 EPHA5 | 3.08e-08 | 1194 | 236 | 37 | GO:0000902 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | EPHB2 MAG RELN SPART ITGA1 PTK2 SCN1B CNTN5 VPS13A ADAM17 DNM2 KIF13B EVL CACNA1F NRDC DSCAM KALRN NR4A3 VPS54 ATP9A KIF20B CELSR2 ZNF335 CAPRIN2 DNM3 FYN EPHA3 EPHA5 | 1.63e-07 | 802 | 236 | 28 | GO:0048812 |
| GeneOntologyBiologicalProcess | neuron development | EPHB2 MAG DLG5 RELN RAP1GAP2 SPART TSHR ITGA1 ADGRV1 PTK2 S100A9 SERPINI1 ALMS1 PTPRG P3H1 SCN1B CNTN5 VPS13A ADAM17 DNM2 KIF13B EVL CACNA1F NRDC DSCAM KALRN TNC NR4A3 FRYL VPS54 INPP5F ATP9A KIF20B CELSR2 ZNF335 CAPRIN2 DNM3 FYN EPHA3 EPHA5 | 2.29e-07 | 1463 | 236 | 40 | GO:0048666 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | EPHB2 MAG RELN SPART ITGA1 PTK2 SCN1B CNTN5 VPS13A ADAM17 DNM2 KIF13B EVL CACNA1F NRDC DSCAM KALRN NR4A3 VPS54 ATP9A KIF20B CELSR2 ZNF335 CAPRIN2 DNM3 FYN EPHA3 EPHA5 | 2.49e-07 | 819 | 236 | 28 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | EPHB2 MAG RELN SPART ITGA1 PTK2 SCN1B CNTN5 VPS13A ADAM17 DNM2 KIF13B EVL CACNA1F NRDC DSCAM KALRN NR4A3 VPS54 ATP9A KIF20B CELSR2 ZNF335 CAPRIN2 DNM3 FYN EPHA3 EPHA5 | 2.96e-07 | 826 | 236 | 28 | GO:0048858 |
| GeneOntologyBiologicalProcess | negative regulation of cell projection organization | EPHB2 MAG RAP1GAP2 SPART PTK2 PTPRG ADAM17 DNM2 EVL INPP5F DNM3 FYN EPHA3 | 3.06e-06 | 233 | 236 | 13 | GO:0031345 |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | EPHB2 MAG RELN RAP1GAP2 SPART PTK2 S100A9 SERPINI1 PTPRG P3H1 SCN1B ADAM17 KIF13B NRDC DSCAM KALRN INPP5F CAPRIN2 DNM3 FYN EPHA3 | 8.17e-06 | 612 | 236 | 21 | GO:0010975 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | DCHS2 PTPRG CNTN5 PCDH10 DSCAM PCDHGB6 PCDHGB3 PCDHGB1 PCDHGA7 CELSR2 PCDHGA12 | 1.08e-05 | 187 | 236 | 11 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | MAG DCHS2 PTPRG CNTN5 PCDH10 DSCAM PCDHGB6 PCDHGB3 PCDHGB1 PCDHGA7 CELSR2 PCDHGA12 MDGA1 EPHA3 | 1.62e-05 | 313 | 236 | 14 | GO:0098742 |
| GeneOntologyBiologicalProcess | axon development | EPHB2 MAG RELN SPART PTK2 SCN1B CNTN5 ADAM17 DNM2 KIF13B EVL CACNA1F NRDC DSCAM KALRN TNC NR4A3 INPP5F FYN EPHA3 EPHA5 | 1.67e-05 | 642 | 236 | 21 | GO:0061564 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | MAG DCHS2 DLG5 ABCA12 EMILIN2 ITGA1 ADGRV1 ITGB6 PTK2 TUBB1 S100A9 PTPRC PTPRG CNTN5 PCDH10 DSCAM PCDHGB6 PCDHGB3 PCDHGB1 PCDHGA7 NR4A3 PDIA3 IFNB1 CELSR2 PCDHGA12 SMARCA2 MDGA1 FYN EPHA3 | 1.69e-05 | 1077 | 236 | 29 | GO:0098609 |
| GeneOntologyBiologicalProcess | negative regulation of neuron projection development | EPHB2 MAG RAP1GAP2 SPART PTK2 PTPRG ADAM17 INPP5F DNM3 EPHA3 | 2.60e-05 | 169 | 236 | 10 | GO:0010977 |
| GeneOntologyBiologicalProcess | axon guidance | EPHB2 RELN PTK2 SCN1B CNTN5 ADAM17 EVL DSCAM KALRN NR4A3 FYN EPHA3 EPHA5 | 2.65e-05 | 285 | 236 | 13 | GO:0007411 |
| GeneOntologyBiologicalProcess | neuron projection guidance | EPHB2 RELN PTK2 SCN1B CNTN5 ADAM17 EVL DSCAM KALRN NR4A3 FYN EPHA3 EPHA5 | 2.75e-05 | 286 | 236 | 13 | GO:0097485 |
| GeneOntologyBiologicalProcess | axonogenesis | EPHB2 MAG RELN SPART PTK2 SCN1B CNTN5 ADAM17 DNM2 KIF13B EVL CACNA1F NRDC DSCAM KALRN NR4A3 FYN EPHA3 EPHA5 | 3.01e-05 | 566 | 236 | 19 | GO:0007409 |
| GeneOntologyBiologicalProcess | ephrin receptor signaling pathway | 3.44e-05 | 54 | 236 | 6 | GO:0048013 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | EPHB2 MAG RELN RAP1GAP2 SPART PTK2 S100A9 SERPINI1 PTPRG P3H1 SCN1B HRAS ADAM17 DNM2 KIF13B EVL NRDC DSCAM KALRN INPP5F CAPRIN2 DNM3 FYN EPHA3 | 4.19e-05 | 846 | 236 | 24 | GO:0120035 |
| GeneOntologyBiologicalProcess | Fc receptor mediated stimulatory signaling pathway | 4.61e-05 | 35 | 236 | 5 | GO:0002431 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | EPHB2 MAG RELN SPART PTK2 SCN1B CNTN5 ADAM17 DNM2 KIF13B EVL CACNA1F NRDC DSCAM KALRN NR4A3 CELSR2 CAPRIN2 DNM3 FYN EPHA3 EPHA5 | 5.24e-05 | 748 | 236 | 22 | GO:0048667 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | EPHB2 MAG RELN RAP1GAP2 SPART PTK2 S100A9 SERPINI1 PTPRG P3H1 SCN1B HRAS ADAM17 DNM2 KIF13B EVL NRDC DSCAM KALRN INPP5F CAPRIN2 DNM3 FYN EPHA3 | 5.73e-05 | 863 | 236 | 24 | GO:0031344 |
| GeneOntologyBiologicalProcess | dendrite morphogenesis | EPHB2 RELN CACNA1F DSCAM KALRN CELSR2 CAPRIN2 DNM3 FYN EPHA5 | 9.87e-05 | 198 | 236 | 10 | GO:0048813 |
| GeneOntologyBiologicalProcess | positive regulation of neuron projection development | EPHB2 RELN S100A9 SERPINI1 P3H1 SCN1B ADAM17 KALRN CAPRIN2 FYN EPHA3 | 1.47e-04 | 249 | 236 | 11 | GO:0010976 |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | EPHB2 RELN S100A9 SERPINI1 P3H1 SCN1B HRAS ADAM17 DNM2 NRDC DSCAM KALRN CAPRIN2 DNM3 FYN EPHA3 | 1.94e-04 | 494 | 236 | 16 | GO:0031346 |
| GeneOntologyBiologicalProcess | synaptic vesicle budding from presynaptic endocytic zone membrane | 2.28e-04 | 11 | 236 | 3 | GO:0016185 | |
| GeneOntologyBiologicalProcess | negative regulation of catalytic activity | EPHB2 SERPINE3 STK38 ADGRV1 ADAR ITIH1 ITIH3 SERPINA4 HEG1 SERPINI1 PTPRC SERPINB12 HRAS PRKAG2 PZP DNAJA1 HIPK3 PLA2R1 | 2.70e-04 | 615 | 236 | 18 | GO:0043086 |
| GeneOntologyBiologicalProcess | dendritic spine morphogenesis | 3.34e-04 | 81 | 236 | 6 | GO:0060997 | |
| GeneOntologyBiologicalProcess | dendritic spine organization | 3.61e-04 | 115 | 236 | 7 | GO:0097061 | |
| GeneOntologyBiologicalProcess | vesicle-mediated intercellular transport | 3.88e-04 | 3 | 236 | 2 | GO:0110077 | |
| GeneOntologyBiologicalProcess | vesicle scission | 3.88e-04 | 3 | 236 | 2 | GO:0099050 | |
| GeneOntologyBiologicalProcess | regulation of autophagosome size | 3.88e-04 | 3 | 236 | 2 | GO:0016243 | |
| GeneOntologyCellularComponent | photoreceptor inner segment | 2.94e-05 | 78 | 237 | 7 | GO:0001917 | |
| GeneOntologyCellularComponent | anchoring junction | DCHS2 DLG5 ARHGAP26 TRPC4 SPTBN2 ITGA1 GRHL2 ITGB6 PTK2 HEG1 PTPRC SCN1B NHS ADAM17 AKR1B1 DNM2 EVL TRIM15 TNC MYZAP PDIA3 XIRP2 PCDHGA12 IL1RL1 EPHA5 | 1.28e-04 | 976 | 237 | 25 | GO:0070161 |
| GeneOntologyCellularComponent | lysosomal HOPS complex | 1.28e-04 | 2 | 237 | 2 | GO:1902501 | |
| GeneOntologyCellularComponent | vacuolar HOPS complex | 1.28e-04 | 2 | 237 | 2 | GO:1902500 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | SPTBN2 RAP1GAP2 ADGRV1 PTK2 GBP4 KCNH2 HRAS DNAJA1 AKR1B1 SEC23B DNM2 STBD1 KALRN FSD2 CPD VPS54 ATP9A FASLG KIF20B AATK DNM3 FYN TP53BP2 EPHA5 | 1.67e-04 | 934 | 237 | 24 | GO:0048471 |
| GeneOntologyCellularComponent | focal adhesion | ARHGAP26 ITGA1 ITGB6 PTK2 PTPRC NHS ADAM17 DNM2 EVL TRIM15 TNC PDIA3 XIRP2 IL1RL1 | 4.31e-04 | 431 | 237 | 14 | GO:0005925 |
| GeneOntologyCellularComponent | cell-substrate junction | ARHGAP26 ITGA1 ITGB6 PTK2 PTPRC NHS ADAM17 DNM2 EVL TRIM15 TNC PDIA3 XIRP2 IL1RL1 | 5.66e-04 | 443 | 237 | 14 | GO:0030055 |
| MousePheno | abnormal gait | MAG DLG5 RELN SPTBN2 SPART CMAS AKR1C2 STARD9 CASKIN1 VPS13A TBX10 PLA2G6 PLCB4 DNM1 PCDH10 IMMT DNM2 SLC12A6 DSCAM VPS54 MCOLN1 ATP13A2 TP53BP2 | 1.54e-06 | 520 | 200 | 23 | MP:0001406 |
| Domain | FN3 | EPHB2 IL13RA1 PTPRC PTPRG CNTN5 LRRN1 DSCAM KALRN TNC FSD2 POMGNT2 MDGA1 EPHA3 EPHA5 | 2.03e-07 | 199 | 232 | 14 | PS50853 |
| Domain | FN3_dom | EPHB2 IL13RA1 PTPRC PTPRG CNTN5 LRRN1 DSCAM KALRN TNC FSD2 POMGNT2 MDGA1 EPHA3 EPHA5 | 3.69e-07 | 209 | 232 | 14 | IPR003961 |
| Domain | FN3 | EPHB2 PTPRC PTPRG CNTN5 LRRN1 DSCAM KALRN TNC FSD2 MDGA1 EPHA3 EPHA5 | 3.57e-06 | 185 | 232 | 12 | SM00060 |
| Domain | fn3 | EPHB2 PTPRC PTPRG CNTN5 LRRN1 DSCAM KALRN TNC FSD2 EPHA3 EPHA5 | 5.91e-06 | 162 | 232 | 11 | PF00041 |
| Domain | Cadherin_C | 1.24e-05 | 42 | 232 | 6 | IPR032455 | |
| Domain | Cadherin_C_2 | 1.24e-05 | 42 | 232 | 6 | PF16492 | |
| Domain | Dynamin_central | 3.68e-05 | 6 | 232 | 3 | IPR000375 | |
| Domain | GED | 3.68e-05 | 6 | 232 | 3 | SM00302 | |
| Domain | Dynamin_M | 3.68e-05 | 6 | 232 | 3 | PF01031 | |
| Domain | GED_dom | 3.68e-05 | 6 | 232 | 3 | IPR020850 | |
| Domain | GED | 3.68e-05 | 6 | 232 | 3 | PS51388 | |
| Domain | Dynamin_GTPase_CS | 3.68e-05 | 6 | 232 | 3 | IPR019762 | |
| Domain | GED | 3.68e-05 | 6 | 232 | 3 | PF02212 | |
| Domain | GED | 3.68e-05 | 6 | 232 | 3 | IPR003130 | |
| Domain | G_DYNAMIN_1 | 6.38e-05 | 7 | 232 | 3 | PS00410 | |
| Domain | DYNc | 6.38e-05 | 7 | 232 | 3 | SM00053 | |
| Domain | Cadherin_CS | DCHS2 PCDH10 PCDHGB6 PCDHGB3 PCDHGB1 PCDHGA7 CELSR2 PCDHGA12 | 6.50e-05 | 109 | 232 | 8 | IPR020894 |
| Domain | CADHERIN_1 | DCHS2 PCDH10 PCDHGB6 PCDHGB3 PCDHGB1 PCDHGA7 CELSR2 PCDHGA12 | 8.39e-05 | 113 | 232 | 8 | PS00232 |
| Domain | Cadherin | DCHS2 PCDH10 PCDHGB6 PCDHGB3 PCDHGB1 PCDHGA7 CELSR2 PCDHGA12 | 8.39e-05 | 113 | 232 | 8 | PF00028 |
| Domain | - | EPHB2 MAG IL13RA1 PTPRC FCER1A PTPRG SCN1B CNTN5 KIR2DL4 STBD1 LRRN1 DSCAM KALRN TNC FSD2 PKHD1L1 POMGNT2 IL1RL1 MDGA1 EPHA3 EPHA5 | 8.58e-05 | 663 | 232 | 21 | 2.60.40.10 |
| Domain | CADHERIN_2 | DCHS2 PCDH10 PCDHGB6 PCDHGB3 PCDHGB1 PCDHGA7 CELSR2 PCDHGA12 | 8.93e-05 | 114 | 232 | 8 | PS50268 |
| Domain | - | DCHS2 PCDH10 PCDHGB6 PCDHGB3 PCDHGB1 PCDHGA7 CELSR2 PCDHGA12 | 8.93e-05 | 114 | 232 | 8 | 2.60.40.60 |
| Domain | Cadherin_tail | 8.93e-05 | 37 | 232 | 5 | PF15974 | |
| Domain | Cadherin_CBD | 8.93e-05 | 37 | 232 | 5 | IPR031904 | |
| Domain | CA | DCHS2 PCDH10 PCDHGB6 PCDHGB3 PCDHGB1 PCDHGA7 CELSR2 PCDHGA12 | 9.49e-05 | 115 | 232 | 8 | SM00112 |
| Domain | Cadherin-like | DCHS2 PCDH10 PCDHGB6 PCDHGB3 PCDHGB1 PCDHGA7 CELSR2 PCDHGA12 | 1.01e-04 | 116 | 232 | 8 | IPR015919 |
| Domain | VIT | 1.01e-04 | 8 | 232 | 3 | PF08487 | |
| Domain | VIT | 1.01e-04 | 8 | 232 | 3 | SM00609 | |
| Domain | Cadherin | DCHS2 PCDH10 PCDHGB6 PCDHGB3 PCDHGB1 PCDHGA7 CELSR2 PCDHGA12 | 1.14e-04 | 118 | 232 | 8 | IPR002126 |
| Domain | Ceramidse_alk_C | 1.54e-04 | 2 | 232 | 2 | PF17048 | |
| Domain | Glycosyltransferase_AER61 | 1.54e-04 | 2 | 232 | 2 | IPR007657 | |
| Domain | DUF563 | 1.54e-04 | 2 | 232 | 2 | PF04577 | |
| Domain | NEUT/ALK_ceramidase_C | 1.54e-04 | 2 | 232 | 2 | IPR031331 | |
| Domain | Ceramidase_alk | 1.54e-04 | 2 | 232 | 2 | IPR006823 | |
| Domain | Cadherin_2 | 1.54e-04 | 65 | 232 | 6 | PF08266 | |
| Domain | Cadherin_N | 1.54e-04 | 65 | 232 | 6 | IPR013164 | |
| Domain | PAS-assoc_C | 2.03e-04 | 24 | 232 | 4 | IPR000700 | |
| Domain | Ig-like_fold | EPHB2 MAG IL13RA1 PTPRC FCER1A PTPRG SCN1B CNTN5 KIR2DL4 STBD1 LRRN1 DSCAM KALRN TNC FSD2 PKHD1L1 POMGNT2 IL1RL1 MDGA1 EPHA3 EPHA5 | 2.04e-04 | 706 | 232 | 21 | IPR013783 |
| Domain | VIT | 2.13e-04 | 10 | 232 | 3 | PS51468 | |
| Domain | VIT | 2.13e-04 | 10 | 232 | 3 | IPR013694 | |
| Domain | VWF_A | 2.35e-04 | 99 | 232 | 7 | IPR002035 | |
| Domain | PAC | 2.80e-04 | 26 | 232 | 4 | IPR001610 | |
| Domain | PAC | 2.80e-04 | 26 | 232 | 4 | PS50113 | |
| Domain | PAC | 2.80e-04 | 26 | 232 | 4 | SM00086 | |
| Domain | - | 3.15e-04 | 74 | 232 | 6 | 3.40.50.410 | |
| Domain | VPS13 | 4.57e-04 | 3 | 232 | 2 | IPR026847 | |
| Domain | K_chnl_volt-dep_ERG | 4.57e-04 | 3 | 232 | 2 | IPR003967 | |
| Domain | ALMS_motif | 4.57e-04 | 3 | 232 | 2 | IPR029299 | |
| Domain | VPS13_mid_rpt | 4.57e-04 | 3 | 232 | 2 | PF16910 | |
| Domain | VPS13 | 4.57e-04 | 3 | 232 | 2 | PF16908 | |
| Domain | VPS13_N2 | 4.57e-04 | 3 | 232 | 2 | IPR031646 | |
| Domain | VPS13_mid_rpt | 4.57e-04 | 3 | 232 | 2 | IPR031642 | |
| Domain | ALMS_motif | 4.57e-04 | 3 | 232 | 2 | PF15309 | |
| Domain | VWFA | 5.49e-04 | 82 | 232 | 6 | PS50234 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 6.22e-04 | 14 | 232 | 3 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 6.22e-04 | 14 | 232 | 3 | PS00790 | |
| Domain | Tyr_kinase_rcpt_V_CS | 6.22e-04 | 14 | 232 | 3 | IPR001426 | |
| Domain | G_DYNAMIN_dom | 6.22e-04 | 14 | 232 | 3 | IPR030381 | |
| Domain | EphA2_TM | 6.22e-04 | 14 | 232 | 3 | PF14575 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 6.22e-04 | 14 | 232 | 3 | IPR001090 | |
| Domain | Eph_TM | 6.22e-04 | 14 | 232 | 3 | IPR027936 | |
| Domain | EPH_lbd | 6.22e-04 | 14 | 232 | 3 | SM00615 | |
| Domain | Ephrin_lbd | 6.22e-04 | 14 | 232 | 3 | PF01404 | |
| Domain | Tyr_kinase_ephrin_rcpt | 6.22e-04 | 14 | 232 | 3 | IPR016257 | |
| Domain | EPH_LBD | 6.22e-04 | 14 | 232 | 3 | PS51550 | |
| Domain | G_DYNAMIN_2 | 6.22e-04 | 14 | 232 | 3 | PS51718 | |
| Domain | VWA | 6.24e-04 | 84 | 232 | 6 | SM00327 | |
| Domain | Serpin_CS | 6.35e-04 | 32 | 232 | 4 | IPR023795 | |
| Domain | PAS | 6.35e-04 | 32 | 232 | 4 | SM00091 | |
| Domain | VWA | 6.46e-04 | 56 | 232 | 5 | PF00092 | |
| Domain | Dynamin_GTPase | 7.71e-04 | 15 | 232 | 3 | IPR001401 | |
| Domain | Dynamin_SF | 7.71e-04 | 15 | 232 | 3 | IPR022812 | |
| Domain | Dynamin_N | 7.71e-04 | 15 | 232 | 3 | PF00350 | |
| Domain | PAS | 8.03e-04 | 34 | 232 | 4 | PS50112 | |
| Domain | PAS | 8.03e-04 | 34 | 232 | 4 | IPR000014 | |
| Domain | Kinesin-like_KIF1-typ | 9.07e-04 | 4 | 232 | 2 | IPR022140 | |
| Domain | HSA | 9.07e-04 | 4 | 232 | 2 | SM00573 | |
| Domain | P5-ATPase | 9.07e-04 | 4 | 232 | 2 | PF12409 | |
| Domain | SHR-BD | 9.07e-04 | 4 | 232 | 2 | IPR009543 | |
| Domain | KIF1B | 9.07e-04 | 4 | 232 | 2 | PF12423 | |
| Domain | HSA | 9.07e-04 | 4 | 232 | 2 | PS51204 | |
| Domain | VPS13_C | 9.07e-04 | 4 | 232 | 2 | PF16909 | |
| Domain | VPS13_C | 9.07e-04 | 4 | 232 | 2 | IPR031645 | |
| Domain | HSA_dom | 9.07e-04 | 4 | 232 | 2 | IPR014012 | |
| Domain | HSA | 9.07e-04 | 4 | 232 | 2 | PF07529 | |
| Domain | SHR-BD | 9.07e-04 | 4 | 232 | 2 | PF06650 | |
| Domain | PH_dom-like | ARHGAP26 SPTBN2 PTK2 CCM2 PLCB4 DNM1 DNM2 EVL KALRN ARHGEF18 DOK4 ELMO2 DNM3 PHLPP2 | 9.27e-04 | 426 | 232 | 14 | IPR011993 |
| Domain | Serpin_dom | 1.00e-03 | 36 | 232 | 4 | IPR023796 | |
| Domain | SERPIN | 1.11e-03 | 37 | 232 | 4 | PS00284 | |
| Domain | SERPIN | 1.11e-03 | 37 | 232 | 4 | SM00093 | |
| Domain | - | 1.19e-03 | 64 | 232 | 5 | 3.40.50.1000 | |
| Domain | SAM_DOMAIN | 1.19e-03 | 95 | 232 | 6 | PS50105 | |
| Domain | Serpin | 1.23e-03 | 38 | 232 | 4 | PF00079 | |
| Domain | - | ARHGAP26 SPTBN2 CCM2 PLCB4 DNM1 DNM2 EVL KALRN ARHGEF18 DOK4 ELMO2 DNM3 PHLPP2 | 1.26e-03 | 391 | 232 | 13 | 2.30.29.30 |
| Domain | PROTEIN_KINASE_TYR | 1.33e-03 | 97 | 232 | 6 | PS00109 | |
| Domain | SAM | 1.33e-03 | 97 | 232 | 6 | IPR001660 | |
| Domain | Tyr_kinase_AS | 1.33e-03 | 97 | 232 | 6 | IPR008266 | |
| Domain | Serpin_fam | 1.36e-03 | 39 | 232 | 4 | IPR000215 | |
| Domain | Syja_N | 1.50e-03 | 5 | 232 | 2 | PF02383 | |
| Domain | P-type_TPase_V | 1.50e-03 | 5 | 232 | 2 | IPR006544 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | EPHB2 RELN SPTBN2 PTK2 TUBB1 PTPRC HRAS DNM1 DNM2 EVL DSCAM KALRN DOK4 DNM3 FYN | 6.66e-07 | 261 | 171 | 15 | MM15676 |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | EPHB2 MAG RELN TRPC4 SPTBN2 ITGA1 ADGRV1 PTK2 TUBB1 PTPRC SCN1B HRAS DNM1 DNM2 EVL DSCAM KALRN DOK4 DNM3 FYN EPHA3 EPHA5 | 1.78e-06 | 575 | 171 | 22 | M29853 |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 1.56e-05 | 92 | 171 | 8 | M27201 | |
| Pathway | REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING | 7.89e-05 | 37 | 171 | 5 | MM15022 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.12e-04 | 121 | 171 | 8 | M872 | |
| Pathway | PID_EPHB_FWD_PATHWAY | 1.16e-04 | 40 | 171 | 5 | M62 | |
| Pathway | REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING | 1.47e-04 | 42 | 171 | 5 | M27308 | |
| Pubmed | DLG5 EMC1 VPS13C ARHGAP26 SPART ADGRV1 MTUS1 CASKIN1 MED12L PITPNM2 EP400 VPS39 HECTD4 ICE1 INPP5F ANKRD50 TRIM33 CAPRIN2 | 3.61e-08 | 529 | 240 | 18 | 14621295 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ARHGAP26 PER1 RAP1GAP2 HIRA HEG1 KCNH2 CASKIN1 PLA2G6 PITPNM2 FRAS1 EP400 NRF1 KALRN VPS39 RTTN HECTD4 FRYL ICE1 CFAP43 ATP13A2 ORC1 AATK POMGNT2 CELSR2 DOK4 ZNF335 | 6.08e-08 | 1105 | 240 | 26 | 35748872 |
| Pubmed | EFCAB5 SPTBN2 EML6 ANKRD30B OR13D1 STARD9 PRRC2C VPS13A DNAJA1 CCDC191 IMMT SLC12A6 KIF13B EVL PCDHGB6 PCDHGB3 PCDHGB1 PCDHGA7 KTN1 DNAH2 CCDC150 PDIA3 NFE2L3 DOK4 SBNO1 PCDHGA12 CTR9 CAPRIN2 ANKRD30A CEP295 | 8.22e-08 | 1442 | 240 | 30 | 35575683 | |
| Pubmed | UBR1 ZNF143 EMC1 ACOT9 TUBGCP4 PTK2 PARP4 PRRC2C DNM1 PZP SEC23B DNM2 FRAS1 NRDC DNAJC16 ANKRD50 SACM1L ELMO2 CTR9 | 1.60e-07 | 650 | 240 | 19 | 38777146 | |
| Pubmed | 3.25e-07 | 3 | 240 | 3 | 12511974 | ||
| Pubmed | 3.25e-07 | 3 | 240 | 3 | 24273169 | ||
| Pubmed | Microtubule-induced focal adhesion disassembly is mediated by dynamin and focal adhesion kinase. | 3.25e-07 | 3 | 240 | 3 | 15895076 | |
| Pubmed | Identification of ocular regulatory functions of core histone variant H3.2. | 3.25e-07 | 3 | 240 | 3 | 36529279 | |
| Pubmed | 3.25e-07 | 3 | 240 | 3 | 12383797 | ||
| Pubmed | Developmental expression of the dynamin family of mechanoenzymes in the mouse epididymis. | 3.25e-07 | 3 | 240 | 3 | 28395327 | |
| Pubmed | 3.25e-07 | 3 | 240 | 3 | 12517701 | ||
| Pubmed | Dynamin triple knockout cells reveal off target effects of commonly used dynamin inhibitors. | 3.25e-07 | 3 | 240 | 3 | 24046449 | |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | 6.87e-07 | 72 | 240 | 7 | 10380929 | |
| Pubmed | ADAM20 STK38 PTK2 CAPN8 BRDT KCNH2 CES4A DNM1 SEC23B DNM2 DNAH2 CPD INPP5F PDIA3 SACM1L HIPK3 NFE2L3 SMARCA2 FYN | 9.16e-07 | 730 | 240 | 19 | 34857952 | |
| Pubmed | 1.09e-06 | 77 | 240 | 7 | 10835267 | ||
| Pubmed | 1.29e-06 | 4 | 240 | 3 | 10100603 | ||
| Pubmed | Overlapping role of dynamin isoforms in synaptic vesicle endocytosis. | 1.29e-06 | 4 | 240 | 3 | 21689597 | |
| Pubmed | 1.29e-06 | 4 | 240 | 3 | 22846998 | ||
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | 1.41e-06 | 80 | 240 | 7 | 10716726 | |
| Pubmed | 3.21e-06 | 5 | 240 | 3 | 9722593 | ||
| Pubmed | KCNH7 VPS13A POLR1B DNM1 DNM2 CACNA1F ORC1 CELSR2 DNM3 KIF13A FYN TP53BP2 | 3.55e-06 | 329 | 240 | 12 | 17474147 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | VPS13C SPTBN2 PARP4 OTUB2 ADRA1D SAMD9L P3H1 VPS13A AHR DNAJA1 PCDH10 CACNA1F RARS1 PCDHGB3 KTN1 DNAH2 ICE1 CEP295 | 4.24e-06 | 736 | 240 | 18 | 29676528 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | EOGT VPS13C ADGRV1 GRHL2 PTK2 PTPRG PLA2G6 PLCB4 PRKAG2 PLOD1 PITPNM2 SLC12A6 EVL LRRN1 NRF1 PCDHGB1 HECTD4 ARHGEF18 CPD FRYL CHST11 VPS54 DNAH1 HIPK3 ZNF33A VPS41 SMARCA2 | 5.11e-06 | 1489 | 240 | 27 | 28611215 |
| Pubmed | 6.39e-06 | 6 | 240 | 3 | 27251629 | ||
| Pubmed | 6.39e-06 | 6 | 240 | 3 | 23640057 | ||
| Pubmed | 6.39e-06 | 6 | 240 | 3 | 18602423 | ||
| Pubmed | 6.39e-06 | 6 | 240 | 3 | 22685302 | ||
| Pubmed | EMC1 ACOT9 STK38 EMILIN2 CMAS ADAR PTPRC P3H1 ADAM17 DNAJA1 PLOD1 IMMT DNM2 RARS1 CPD POMGNT2 | 6.55e-06 | 613 | 240 | 16 | 22268729 | |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 6.77e-06 | 101 | 240 | 7 | 23382219 | |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | 7.76e-06 | 68 | 240 | 6 | 11230163 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | EFCAB5 ABCA13 ARHGAP26 MTUS1 GLRX VPS13A ARMH3 KALRN PCDHGA7 CHST11 ATP9A HIPK3 PLA2R1 CSHL1 ZNF335 | 7.96e-06 | 552 | 240 | 15 | 10737800 |
| Pubmed | 1.11e-05 | 7 | 240 | 3 | 9632142 | ||
| Pubmed | 1.11e-05 | 7 | 240 | 3 | 15252009 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | EPHB2 GLT8D1 EOGT EMC1 ITGA1 NXPE3 HEG1 SERPINI1 P3H1 ADAM17 PLOD1 FRAS1 BZW2 DNAJC16 KTN1 IKBKG CPD ATP9A PDIA3 SACM1L PLA2R1 POMGNT2 CELSR2 | 1.13e-05 | 1201 | 240 | 23 | 35696571 |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | 1.27e-05 | 74 | 240 | 6 | 10817752 | |
| Pubmed | TRPC4 SPTBN2 ITIH1 PTK2 HIRA PRRC2C CASKIN1 HRAS DNM1 DNAJA1 DNM2 KIF13B DSCAM KALRN KTN1 HECTD4 ARHGEF18 CELSR2 DNM3 TP53BP2 | 1.37e-05 | 963 | 240 | 20 | 28671696 | |
| Pubmed | NYAP: a phosphoprotein family that links PI3K to WAVE1 signalling in neurons. | 1.47e-05 | 22 | 240 | 4 | 21946561 | |
| Pubmed | 1.77e-05 | 8 | 240 | 3 | 12526740 | ||
| Pubmed | 1.77e-05 | 8 | 240 | 3 | 24282027 | ||
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 2.09e-05 | 120 | 240 | 7 | 31413325 | |
| Pubmed | 2.46e-05 | 83 | 240 | 6 | 11114734 | ||
| Pubmed | 2.64e-05 | 9 | 240 | 3 | 11403717 | ||
| Pubmed | 2.64e-05 | 9 | 240 | 3 | 21081122 | ||
| Pubmed | 2.64e-05 | 9 | 240 | 3 | 23170932 | ||
| Pubmed | 2.79e-05 | 172 | 240 | 8 | 27375898 | ||
| Pubmed | WDR76 is a RAS binding protein that functions as a tumor suppressor via RAS degradation. | 2.99e-05 | 52 | 240 | 5 | 30655611 | |
| Pubmed | 3.42e-05 | 177 | 240 | 8 | 26206133 | ||
| Pubmed | 3.76e-05 | 10 | 240 | 3 | 23746204 | ||
| Pubmed | 3.76e-05 | 10 | 240 | 3 | 10398046 | ||
| Pubmed | ACOT9 SPART TUBGCP4 ADAR DNAJA1 IMMT NUP160 DNM2 NRDC BZW2 CPD TRIM33 ELMO2 CTR9 | 3.98e-05 | 560 | 240 | 14 | 35241646 | |
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 12388760 | ||
| Pubmed | TRPML1 and RAS-driven cancers - exploring a link with great therapeutic potential. | 4.74e-05 | 2 | 240 | 2 | 31526156 | |
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 14578863 | ||
| Pubmed | Genomic structure and promoter analysis of the mouse neutral ceramidase gene. | 4.74e-05 | 2 | 240 | 2 | 12435403 | |
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 34668726 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 16028072 | ||
| Pubmed | NRF1 Alleviated Oxidative Stress of Glioblastoma Cells by Regulating NOR1. | 4.74e-05 | 2 | 240 | 2 | 37962027 | |
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 22317973 | ||
| Pubmed | A novel gene derived from a segmental duplication shows perturbed expression in Alzheimer's disease. | 4.74e-05 | 2 | 240 | 2 | 17334805 | |
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 25239130 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 34274446 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 10753931 | ||
| Pubmed | Tandem orientation of the inter-alpha-trypsin inhibitor heavy chain H1 and H3 genes. | 4.74e-05 | 2 | 240 | 2 | 7522574 | |
| Pubmed | The aryl hydrocarbon receptor predisposes hepatocytes to Fas-mediated apoptosis. | 4.74e-05 | 2 | 240 | 2 | 15550680 | |
| Pubmed | Mitochondrial clearance by the STK38 kinase supports oncogenic Ras-induced cell transformation. | 4.74e-05 | 2 | 240 | 2 | 27283898 | |
| Pubmed | Expression of S100A9 and KL-6 in common interstitial lung diseases. | 4.74e-05 | 2 | 240 | 2 | 35512076 | |
| Pubmed | Adenosine deaminase acting on RNA 1 (ADAR1) suppresses the induction of interferon by measles virus. | 4.74e-05 | 2 | 240 | 2 | 22278222 | |
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 34876700 | ||
| Pubmed | An intramolecular signaling element that modulates dynamin function in vitro and in vivo. | 4.74e-05 | 2 | 240 | 2 | 19515832 | |
| Pubmed | Human pre-alpha-trypsin inhibitor-precursor heavy chain. cDNA and deduced amino-acid sequence. | 4.74e-05 | 2 | 240 | 2 | 7681778 | |
| Pubmed | Tumor necrosis factor-alpha converting enzyme/ADAM 17 mediates MUC1 shedding. | 4.74e-05 | 2 | 240 | 2 | 12441351 | |
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 20410486 | ||
| Pubmed | Integrin alpha1 localization in murine central and peripheral nervous system. | 4.74e-05 | 2 | 240 | 2 | 9603370 | |
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 35354041 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 22977254 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 24373612 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 19359372 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 24659784 | ||
| Pubmed | Calgranulin B and KL-6 in Bronchoalveolar Lavage of Patients with IPF and NSIP. | 4.74e-05 | 2 | 240 | 2 | 30680696 | |
| Pubmed | Mutagenesis as an unbiased approach to identify novel contraceptive targets. | 4.74e-05 | 2 | 240 | 2 | 16412559 | |
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 19553453 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 29361535 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 32986180 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 11782545 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 22310717 | ||
| Pubmed | Neutral ceramidase deficiency protects against cisplatin-induced acute kidney injury. | 4.74e-05 | 2 | 240 | 2 | 35151662 | |
| Pubmed | Cerebral cavernous malformations arise independent of the heart of glass receptor. | 4.74e-05 | 2 | 240 | 2 | 24643410 | |
| Pubmed | Dynamin 2-dependent endocytosis is essential for mouse oocyte development and fertility. | 4.74e-05 | 2 | 240 | 2 | 32065700 | |
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 37944753 | ||
| Pubmed | Structural basis of gene regulation by the Grainyhead/CP2 transcription factor family. | 4.74e-05 | 2 | 240 | 2 | 29309642 | |
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 11280766 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 27609772 | ||
| Pubmed | ALMS1 and Alström syndrome: a recessive form of metabolic, neurosensory and cardiac deficits. | 4.74e-05 | 2 | 240 | 2 | 30421101 | |
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 27191989 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 7525550 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 11328816 | ||
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 21670293 | ||
| Pubmed | Downregulation of neutral ceramidase by gemcitabine: Implications for cell cycle regulation. | 4.74e-05 | 2 | 240 | 2 | 19345744 | |
| Pubmed | Lactosylceramide contributes to mitochondrial dysfunction in diabetes. | 4.74e-05 | 2 | 240 | 2 | 26900161 | |
| Pubmed | 4.74e-05 | 2 | 240 | 2 | 17974963 | ||
| Interaction | PCDHGB2 interactions | 7.75e-07 | 44 | 238 | 7 | int:PCDHGB2 | |
| Interaction | LYPD6 interactions | 2.16e-06 | 33 | 238 | 6 | int:LYPD6 | |
| Interaction | PSG8 interactions | 8.10e-06 | 41 | 238 | 6 | int:PSG8 | |
| Interaction | MND1 interactions | 1.61e-05 | 46 | 238 | 6 | int:MND1 | |
| Interaction | CD68 interactions | 2.91e-05 | 31 | 238 | 5 | int:CD68 | |
| Interaction | TRIM52 interactions | 2.94e-05 | 133 | 238 | 9 | int:TRIM52 | |
| Interaction | PCDHGB1 interactions | 3.49e-05 | 77 | 238 | 7 | int:PCDHGB1 | |
| Cytoband | 5q31 | 3.35e-05 | 115 | 240 | 6 | 5q31 | |
| Cytoband | 3p21.1 | 6.97e-05 | 42 | 240 | 4 | 3p21.1 | |
| GeneFamily | Fibronectin type III domain containing | 2.03e-06 | 160 | 164 | 10 | 555 | |
| GeneFamily | Ankyrin repeat domain containing | ANKRD31 TRPC4 ANKRD30B ANKRD18B CASKIN1 PLA2G6 ANKRD30BL ANKRD50 ANKRD30A TP53BP2 | 7.43e-05 | 242 | 164 | 10 | 403 |
| GeneFamily | Sterile alpha motif domain containing | 1.49e-04 | 88 | 164 | 6 | 760 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 2.48e-04 | 14 | 164 | 3 | 1095 | |
| GeneFamily | Clustered protocadherins | 2.86e-04 | 64 | 164 | 5 | 20 | |
| GeneFamily | Serpin peptidase inhibitors | 3.41e-04 | 37 | 164 | 4 | 739 | |
| GeneFamily | O-linked N-acetylglucosaminyltransferases|Tetratricopeptide repeat domain containing | 4.85e-04 | 4 | 164 | 2 | 446 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 6.74e-04 | 161 | 164 | 7 | 593 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 7.92e-04 | 46 | 164 | 4 | 622 | |
| GeneFamily | Parkinson disease associated genes|ATPase orphan transporters | 8.03e-04 | 5 | 164 | 2 | 1213 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.78e-03 | 206 | 164 | 7 | 682 | |
| Coexpression | RAF_UP.V1_UP | PEG10 ARHGAP26 ITGB6 S100A9 HEG1 SERPINI1 GLRX NR4A3 NFE2L3 CAPRIN2 FYN | 1.67e-06 | 193 | 238 | 11 | M2728 |
| Coexpression | NABA_ECM_REGULATORS | SERPINE3 ADAM20 ITIH1 ITIH3 SERPINA4 SERPINI1 P3H1 SERPINB12 ADAM17 PZP PLOD1 | 1.24e-05 | 238 | 238 | 11 | M3468 |
| Coexpression | GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP | 1.51e-05 | 199 | 238 | 10 | M8381 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | EPHB2 GLT8D1 VPS13C SQLE ALMS1 MTUS1 STARD9 VPS13A MED12L NHS DNAJA1 LRRN1 KTN1 HECTD4 DNAH2 KIF20B CELSR2 IPMK EPHA3 PHLPP2 EPHA5 | 1.26e-05 | 654 | 234 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RELN ABCA13 ABCA12 ADGRV1 CAPN8 PCDH10 CACNA1F FRAS1 KALRN PKHD1L1 DNAH1 XIRP2 EPHA5 | 2.63e-11 | 184 | 240 | 13 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RELN ABCA13 ABCA12 ADGRV1 CAPN8 PCDH10 CACNA1F FRAS1 KALRN PKHD1L1 DNAH1 XIRP2 EPHA5 | 2.63e-11 | 184 | 240 | 13 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RELN ABCA13 ABCA12 ADGRV1 CAPN8 PCDH10 CACNA1F FRAS1 KALRN PKHD1L1 DNAH1 XIRP2 EPHA5 | 2.63e-11 | 184 | 240 | 13 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RBM44 ABCA13 CCDC178 ADGRV1 PDILT CES4A DMBT1 FRAS1 SLC6A11 L3MBTL4 EPHA5 | 4.27e-10 | 145 | 240 | 11 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | ABCA13 CCDC178 ADGRV1 PDILT CES4A DMBT1 FRAS1 PKHD1L1 SLC6A11 L3MBTL4 EPHA5 | 1.39e-09 | 162 | 240 | 11 | bf886e22ff2a20353499004b53f25fb9e6574896 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PLB1 ABCA12 ADGRV1 CAPN8 PTPRG TDRD6 FRAS1 PTCHD4 PKHD1L1 EPHA5 | 1.75e-08 | 160 | 240 | 10 | c381ec6be8cf887861cc18f831a20db42f953fe1 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PLB1 ABCA12 ADGRV1 CAPN8 PTPRG TDRD6 FRAS1 PTCHD4 PKHD1L1 EPHA5 | 1.75e-08 | 160 | 240 | 10 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.85e-08 | 161 | 240 | 10 | d72c572613f8eff3251cb7b1e9dcc76d193b2f21 | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | HEMGN CMAS TUBB1 KCNH2 MED12L PLCB4 KALRN PKHD1L1 XIRP2 DNM3 | 8.04e-08 | 188 | 240 | 10 | c00ba0abd0c7bb2c8f9166a2ac6220aae4f4d857 |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.43e-07 | 200 | 240 | 10 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-07 | 169 | 240 | 9 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.04e-07 | 176 | 240 | 9 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.29e-07 | 177 | 240 | 9 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l14|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.08e-07 | 132 | 240 | 8 | 14a512f433315892bf0326419f23d0d5919d01ec | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.56e-07 | 190 | 240 | 9 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.56e-07 | 190 | 240 | 9 | 64060e4b56ac9989e659c2d5d2a6b6edeba4d8d4 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.99e-07 | 191 | 240 | 9 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.09e-06 | 193 | 240 | 9 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.24e-06 | 196 | 240 | 9 | 05b437af66cb43ba098ea93a02dc2f7430bf8c1b | |
| ToppCell | moderate-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.35e-06 | 198 | 240 | 9 | 0a868098b1ee4b28b2149ed766acb09e9c0ce14c | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.40e-06 | 199 | 240 | 9 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-06 | 199 | 240 | 9 | f5c3561744e2a0e7716657cb521acb1d8f054b41 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | 4.06e-06 | 170 | 240 | 8 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.03e-06 | 175 | 240 | 8 | 284fdc7a9d303636a637041846850d19d114861a | |
| ToppCell | COVID-19_Mild-Neu_3|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 5.25e-06 | 176 | 240 | 8 | 2049767fd591045cfcf5b1071d80798e52843f27 | |
| ToppCell | Adult-Epithelial-club_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.47e-06 | 177 | 240 | 8 | d652b7d84fe6aa38319d8d5adc72c70441bd0088 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.70e-06 | 178 | 240 | 8 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | PBMC-Convalescent-Hematopoietic|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.94e-06 | 179 | 240 | 8 | 35271a4396a533f6d960ce55d171a32d9d2fd1a4 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 5.94e-06 | 179 | 240 | 8 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | (5)_Epithelial_cells-(5)_Glands_mucous|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 6.19e-06 | 180 | 240 | 8 | a4118adaf4b09e2ca01b662ed60e7bbf32a24d58 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.45e-06 | 181 | 240 | 8 | 986c036e656f24fe374807e2711cec9e3c83c892 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related-Microfold_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.45e-06 | 181 | 240 | 8 | 4d7d367f4ed390908888391335c714a22b5a75c4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.99e-06 | 183 | 240 | 8 | cfae90c309622b5d499e62a3a8a8b9746478d28d | |
| ToppCell | AT2_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 7.17e-06 | 131 | 240 | 7 | ff4e618bd944f852bbd34438f740187aca82460f | |
| ToppCell | LPS_only-Hematopoietic_Meg-Ery-Erythroid-Erythroid|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.87e-06 | 186 | 240 | 8 | e5014443e9d6e25943308483e20d48b776ae5373 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.87e-06 | 186 | 240 | 8 | 8915436d09775f2828a7678af203b1082b36e21c | |
| ToppCell | LPS_only-Hematopoietic_Meg-Ery-Erythroid|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.87e-06 | 186 | 240 | 8 | affc246a1091e44dc85a5e237c778a7541d5a2b4 | |
| ToppCell | LPS_only-Hematopoietic_Meg-Ery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.87e-06 | 186 | 240 | 8 | 40d1e15402fdfb3b5ae850a2070cd4b68fda3159 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 7.87e-06 | 186 | 240 | 8 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.19e-06 | 187 | 240 | 8 | 34cad5ac8602fe88ca3d421257190c9a388d4cb0 | |
| ToppCell | COPD-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 8.19e-06 | 187 | 240 | 8 | 030af361f8bdcd0aff4ec1922702833325cf74d8 | |
| ToppCell | COPD-Epithelial-ATII|COPD / Disease state, Lineage and Cell class | 8.51e-06 | 188 | 240 | 8 | eb6d79d733b53f64ca615bb777c64ed456866549 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 9.16e-06 | 136 | 240 | 7 | edfd453c9a650d69d05a5a3ab15f7df56349fa86 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 9.16e-06 | 136 | 240 | 7 | 03e4e2353c23ceffde35b2d0aadd15299e3db09f | |
| ToppCell | Adult-Epithelial-club_cell|Adult / Lineage, Cell type, age group and donor | 9.19e-06 | 190 | 240 | 8 | 756bff697d30aec56c0ebfca94295f084a15bf37 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.55e-06 | 191 | 240 | 8 | 5a67ff17fb4b9eff641176dff07830c9cd73754e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.55e-06 | 191 | 240 | 8 | 55ab2854a02cdcfc395e49870ccb7290b5e5471d | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.55e-06 | 191 | 240 | 8 | 156b467187331ac6ca390d6ca861d9670bb7b956 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-T_cells-TRGV4_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.92e-06 | 192 | 240 | 8 | f4b5a55a648e366234079411b6fdd2da75a4740e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.92e-06 | 192 | 240 | 8 | f7e7491426bbd6ed29a465b58bf67acb93dbb90a | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.03e-05 | 193 | 240 | 8 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.03e-05 | 193 | 240 | 8 | 7c34abdcb8839b9fb25457a79af6c5e7b9714b21 | |
| ToppCell | distal-Hematologic-Basophil/Mast_1-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.11e-05 | 195 | 240 | 8 | 4f83449fce3717518e2acbba1a4b3bea765c0bdb | |
| ToppCell | Basal_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.15e-05 | 196 | 240 | 8 | 3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-05 | 198 | 240 | 8 | 0a172c6d997c7cfbad34b56e80121bd104dee67d | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 1.24e-05 | 198 | 240 | 8 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 1.24e-05 | 198 | 240 | 8 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.27e-05 | 143 | 240 | 7 | 28e936c298a45f88d14f0146caf3d5a22d483cd5 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.29e-05 | 199 | 240 | 8 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.29e-05 | 199 | 240 | 8 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 1.29e-05 | 199 | 240 | 8 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | Tracheal-NucSeq-Stromal-Schwann-Schwann_Myelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.29e-05 | 199 | 240 | 8 | 4e4bdcd2e8b518156d5ebd294804180acaa3566b | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.33e-05 | 200 | 240 | 8 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.33e-05 | 200 | 240 | 8 | bcd1cc96197929d6011903803b6f4ccdcf52b4ce | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.33e-05 | 200 | 240 | 8 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.33e-05 | 200 | 240 | 8 | 89821a264e872ed53e08e9d3609d5cc5c314503e | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.33e-05 | 200 | 240 | 8 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Artery|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.33e-05 | 200 | 240 | 8 | ac9ead34afa14067171833f5c277eaf06db7b02e | |
| ToppCell | LPS_anti-TNF-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.33e-05 | 200 | 240 | 8 | 1d105eeda5a2c51f9a4654ffc79b7e2348ad593b | |
| ToppCell | LPS_IL1RA-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.33e-05 | 200 | 240 | 8 | fa1eaf008b54bdf7bbcdec8134460c5f64490de9 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Erythro-Megakary-Erythro-Mega|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.33e-05 | 200 | 240 | 8 | f99e214eb680fd82a33f2b1524fbfca265d1cc42 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.33e-05 | 200 | 240 | 8 | 60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af | |
| ToppCell | LPS_IL1RA-Hematopoietic_Erythro-Megakary|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.33e-05 | 200 | 240 | 8 | d85074b362b11e5a523a5325d203a61aa2759a7a | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / Treatment groups by lineage, cell group, cell type | 1.33e-05 | 200 | 240 | 8 | b17eb1587ca86c3d40515128a00a8d8fd787fccf | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.33e-05 | 200 | 240 | 8 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.33e-05 | 200 | 240 | 8 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.33e-05 | 200 | 240 | 8 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.33e-05 | 200 | 240 | 8 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.33e-05 | 200 | 240 | 8 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.33e-05 | 200 | 240 | 8 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | 356C-Myeloid-Mast_cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.59e-05 | 148 | 240 | 7 | 1668d8a9e680da335362744f36b05446c499347e | |
| ToppCell | 356C-Myeloid-Mast_cell-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.59e-05 | 148 | 240 | 7 | 18511ba10765eda937c5a710626361f7e6b9b321 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-05 | 155 | 240 | 7 | c58a5fb8d853f12204e961d633e83452eb12a659 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-05 | 155 | 240 | 7 | 9cb8c42c2e451b2d4dcd7154a4b1bfd21bbb7ea8 | |
| ToppCell | Control-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.14e-05 | 155 | 240 | 7 | 0a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 2.52e-05 | 159 | 240 | 7 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-TRGV2_gdT|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.96e-05 | 163 | 240 | 7 | 004765e016c5658ee4a8bda4899804303064727b | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass | 3.08e-05 | 164 | 240 | 7 | 362c16ed7fb37bf16601fd5e059d3f3e2ed692b4 | |
| ToppCell | Dendritic_Cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 3.33e-05 | 166 | 240 | 7 | fbeb74b98b58085de323f744b18d4a8f7b22d5d4 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell-mesothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.46e-05 | 167 | 240 | 7 | 1adb566f98af0109c8cc6e36033b89651e2c75e7 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.46e-05 | 167 | 240 | 7 | 743df5908c1ceb43b34b240d9f9649f30f4142fa | |
| ToppCell | Severe-Lymphoid-NK-CD8_T|Severe / Condition, Lineage, Cell class and cell subclass | 3.46e-05 | 167 | 240 | 7 | 8d41015871616ab7eced5104cd8f70d0efe504f2 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.87e-05 | 170 | 240 | 7 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | NS-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.02e-05 | 171 | 240 | 7 | adda76991d9b150bb8ccf3989b7cbbf41843cf0b | |
| ToppCell | Control-B_naive-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.02e-05 | 171 | 240 | 7 | d18855b24aadea38fd1e4592f945cf15b85e05f1 | |
| ToppCell | metastatic_Brain-B_lymphocytes-Undetermined|B_lymphocytes / Location, Cell class and cell subclass | 4.02e-05 | 171 | 240 | 7 | 0d14bc9688c427ba2265984987dc3eea195b19eb | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.17e-05 | 172 | 240 | 7 | adc09c4d1b63fe84150516beb692db1e7f7ac980 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 4.17e-05 | 172 | 240 | 7 | c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.17e-05 | 172 | 240 | 7 | 1bbf5ed7d13635f9a7e528060341e0652699bd7c | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-05 | 174 | 240 | 7 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 1.09e-06 | 43 | 233 | 6 | DOID:2476 (implicated_via_orthology) | |
| Disease | mean platelet volume | EML6 STK38 TUBB1 PTPRC HTR3D ATP13A3 PITPNM2 SLC12A6 ARGFX NRDC NRF1 PCDHGB6 KALRN PCDHGB3 PCDHGB1 BZW2 PCDHGA7 RTTN FRYL BTBD2 MCOLN1 PCDHGA12 CTR9 DNM3 | 2.10e-06 | 1020 | 233 | 24 | EFO_0004584 |
| Disease | centronuclear myopathy 1 (implicated_via_orthology) | 4.80e-06 | 5 | 233 | 3 | DOID:0111223 (implicated_via_orthology) | |
| Disease | microcytic anemia (implicated_via_orthology) | 4.80e-06 | 5 | 233 | 3 | DOID:11252 (implicated_via_orthology) | |
| Disease | irritable bowel syndrome (implicated_via_orthology) | 4.80e-06 | 5 | 233 | 3 | DOID:9778 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease dominant intermediate B (implicated_via_orthology) | 4.80e-06 | 5 | 233 | 3 | DOID:0110197 (implicated_via_orthology) | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 2.12e-05 | 71 | 233 | 6 | EFO_0007878, EFO_0007979 | |
| Disease | Sarcosine measurement | 2.98e-05 | 23 | 233 | 4 | EFO_0021668 | |
| Disease | lymphocyte count | EML6 RAP1GAP2 ITGA1 TIMMDC1 GRHL2 PTPRC ALMS1 ZNF644 CNTN5 PDILT MED12L POLR1B PLA2G6 DMBT1 NUP160 FRAS1 PCDHGB6 KALRN PCDHGB3 PCDHGB1 PCDHGA7 HECTD4 ARHGEF18 NFE2L3 SBNO1 PCDHGA12 ERCC6L2 | 3.96e-05 | 1464 | 233 | 27 | EFO_0004587 |
| Disease | mental development measurement | 4.21e-05 | 25 | 233 | 4 | EFO_0008230 | |
| Disease | ATYPICAL MYCOBACTERIOSIS, FAMILIAL, X-LINKED 1 (disorder) | 6.21e-05 | 2 | 233 | 2 | C1970879 | |
| Disease | Parkinson's disease 23 (implicated_via_orthology) | 6.21e-05 | 2 | 233 | 2 | DOID:0060896 (implicated_via_orthology) | |
| Disease | choreaacanthocytosis (implicated_via_orthology) | 6.21e-05 | 2 | 233 | 2 | DOID:0050766 (implicated_via_orthology) | |
| Disease | Immunodeficiency without anhidrotic ectodermal dysplasia | 6.21e-05 | 2 | 233 | 2 | C1845117 | |
| Disease | Pancreatic Ductal Adenocarcinoma | 7.65e-05 | 11 | 233 | 3 | C1335302 | |
| Disease | Schizophrenia | MAG RELN ABCA13 SPTBN2 ITIH1 ITIH3 S100A9 SERPINI1 KCNH2 HTR3D PLA2G6 DNM1 CACNA1F VPS39 SLC6A11 SBNO1 SMARCA2 MDGA1 FYN | 8.35e-05 | 883 | 233 | 19 | C0036341 |
| Disease | collagen disease (implicated_via_orthology) | 1.01e-04 | 12 | 233 | 3 | DOID:854 (implicated_via_orthology) | |
| Disease | Neurodegeneration with brain iron accumulation | 1.31e-04 | 13 | 233 | 3 | cv:C2931845 | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 1.31e-04 | 13 | 233 | 3 | DOID:0112202 (implicated_via_orthology) | |
| Disease | platelet-to-lymphocyte ratio | STK38 RAP1GAP2 TUBB1 PTPRC MED12L ARMH3 NUP160 KALRN ARHGEF18 PLA2R1 DNM3 | 1.61e-04 | 363 | 233 | 11 | EFO_0008446 |
| Disease | autosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology) | 1.85e-04 | 3 | 233 | 2 | DOID:0111611 (implicated_via_orthology) | |
| Disease | Cohen syndrome (implicated_via_orthology) | 1.85e-04 | 3 | 233 | 2 | DOID:0111590 (implicated_via_orthology) | |
| Disease | Parkinson's disease (implicated_via_orthology) | 2.61e-04 | 157 | 233 | 7 | DOID:14330 (implicated_via_orthology) | |
| Disease | platelet component distribution width | STK38 HEMGN TUBB1 PTPRC PRRC2C CNTN5 PLA2G6 ATP13A3 DNM1 NRF1 KALRN RTTN BTBD2 TRIM33 SIDT2 DNM3 | 3.60e-04 | 755 | 233 | 16 | EFO_0007984 |
| Disease | juvenile-onset Parkinson's disease (implicated_via_orthology) | 3.69e-04 | 4 | 233 | 2 | DOID:0060893 (implicated_via_orthology) | |
| Disease | asialoglycoprotein receptor 1 measurement | 3.69e-04 | 4 | 233 | 2 | EFO_0020164 | |
| Disease | Kufor-Rakeb syndrome (implicated_via_orthology) | 3.69e-04 | 4 | 233 | 2 | DOID:0060556 (implicated_via_orthology) | |
| Disease | creatinine measurement | ADGRV1 GRHL2 ALMS1 SLC35F3 PRRC2C PDILT AHR PLA2G6 PRKAG2 AKR1B1 STBD1 DSCAM NRF1 DNAJC16 ARHGEF18 FSD2 CELSR2 MUC1 ASAH2B | 3.78e-04 | 995 | 233 | 19 | EFO_0004518 |
| Disease | uric acid measurement | ARHGAP26 TSHR ADGRV1 TMEM11 CCM2 PRKAG2 AKR1B1 FRAS1 NAALAD2 DSCAM DNAJC16 HECTD4 ANKRD50 MUC1 | 3.84e-04 | 610 | 233 | 14 | EFO_0004761 |
| Disease | Malignant Neoplasms | 5.53e-04 | 128 | 233 | 6 | C0006826 | |
| Disease | depressive symptom measurement, herpes virus seropositivity | 6.11e-04 | 5 | 233 | 2 | EFO_0007006, EFO_0007036 | |
| Disease | low density lipoprotein cholesterol measurement, response to escitalopram, response to citalopram | 8.70e-04 | 24 | 233 | 3 | EFO_0004611, EFO_0006329, EFO_0007871 | |
| Disease | glomerular filtration rate, creatine measurement | 9.12e-04 | 6 | 233 | 2 | EFO_0005208, EFO_0010472 | |
| Disease | Malignant neoplasm of breast | TRPC4 PER1 ADAR PTPRC ZNF644 HRAS AHR NHS PLOD1 EVL PCDHGB6 KALRN VPS39 KTN1 MCOLN1 IFNB1 SBNO1 ANKRD30A TP53BP2 | 9.44e-04 | 1074 | 233 | 19 | C0006142 |
| Disease | amino acid measurement | EPHB2 ABCA12 GRHL1 ADRA1D SERPINI1 ALMS1 PTPRG CNTN5 HTR3D DNM1 MGAM2 LRRN1 CHST11 PLA2R1 | 1.07e-03 | 678 | 233 | 14 | EFO_0005134 |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.25e-03 | 264 | 233 | 8 | EFO_0008317, EFO_0020944 | |
| Disease | beta-citrylglutamate measurement | 1.27e-03 | 7 | 233 | 2 | EFO_0800060 | |
| Disease | catalase measurement | 1.27e-03 | 7 | 233 | 2 | EFO_0008071 | |
| Disease | Adenocarcinoma of lung (disorder) | 1.31e-03 | 206 | 233 | 7 | C0152013 | |
| Disease | Bipolar Disorder | RELN ABCA13 ITIH1 ITIH3 STARD9 PLA2G6 GPRC5D SLC12A6 DSCAM MDGA1 FYN | 1.54e-03 | 477 | 233 | 11 | C0005586 |
| Disease | triglycerides to total lipids in medium VLDL percentage | 1.57e-03 | 63 | 233 | 4 | EFO_0022335 | |
| Disease | platelet crit | ANKRD31 HEMGN ADGRV1 TUBB1 PTPRC CNTN5 POLR1B PLOD1 NUP160 NPAT ZNF487 NRF1 KALRN RTTN BTBD2 PLA2R1 SBNO1 | 1.58e-03 | 952 | 233 | 17 | EFO_0007985 |
| Disease | ribose-5-phosphate measurement, ribulose-5-phosphate measurement | 1.68e-03 | 8 | 233 | 2 | EFO_0010529, EFO_0010530 | |
| Disease | irritable bowel syndrome (biomarker_via_orthology) | 1.68e-03 | 8 | 233 | 2 | DOID:9778 (biomarker_via_orthology) | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 1.68e-03 | 8 | 233 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 2.00e-03 | 222 | 233 | 7 | EFO_0008317, EFO_0020943 | |
| Disease | Squamous cell carcinoma of lung | 2.04e-03 | 32 | 233 | 3 | C0149782 | |
| Disease | anxiety | 2.05e-03 | 223 | 233 | 7 | EFO_0005230 | |
| Disease | Benign Neoplasm | 2.08e-03 | 68 | 233 | 4 | C0086692 | |
| Disease | Neoplasms | 2.08e-03 | 68 | 233 | 4 | C0027651 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 2.10e-03 | 224 | 233 | 7 | EFO_0004530, EFO_0008317 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 2.15e-03 | 9 | 233 | 2 | C3502809 | |
| Disease | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer | 2.19e-03 | 69 | 233 | 4 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992 | |
| Disease | chemokine (C-C motif) ligand 27 measurement | 2.31e-03 | 70 | 233 | 4 | EFO_0008082 | |
| Disease | Rheumatoid Arthritis | 2.67e-03 | 174 | 233 | 6 | C0003873 | |
| Disease | sweet beverage consumption measurement | 2.68e-03 | 10 | 233 | 2 | EFO_0010090 | |
| Disease | long QT syndrome (implicated_via_orthology) | 2.68e-03 | 10 | 233 | 2 | DOID:2843 (implicated_via_orthology) | |
| Disease | bilirubin measurement | UBR1 DCHS2 CNTN5 AHR DMBT1 ANKRD50 CRAT PLA2R1 ASAH2B L3MBTL4 | 2.86e-03 | 442 | 233 | 10 | EFO_0004570 |
| Disease | Developmental delay (disorder) | 3.10e-03 | 37 | 233 | 3 | C0424605 | |
| Disease | triglyceride measurement, C-reactive protein measurement | 3.34e-03 | 38 | 233 | 3 | EFO_0004458, EFO_0004530 | |
| Disease | chronic obstructive pulmonary disease | EFCAB5 DCHS2 ITGA1 ELOVL4 CNTN5 DMBT1 DNM2 TRIM15 FRAS1 VPS54 ERCC6L2 IL1RL1 KIF13A | 3.44e-03 | 688 | 233 | 13 | EFO_0000341 |
| Disease | platelet measurement | 3.73e-03 | 315 | 233 | 8 | EFO_0005036 | |
| Disease | free cholesterol in medium LDL measurement | 3.87e-03 | 40 | 233 | 3 | EFO_0022268 | |
| Disease | nicotine dependence (implicated_via_orthology) | 3.89e-03 | 12 | 233 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | liver cirrhosis (is_marker_for) | 4.10e-03 | 82 | 233 | 4 | DOID:5082 (is_marker_for) | |
| Disease | Congenital small ears | 4.15e-03 | 41 | 233 | 3 | C0152423 | |
| Disease | FEV/FEC ratio | EFCAB5 DCHS2 VPS13C ARHGAP26 KIAA0586 ITGA1 PTK2 BRDT MTUS1 CNTN5 DMBT1 PCDH10 FRAS1 ARHGEF18 ATP13A2 TRIM33 ERCC6L2 IL1RL1 KIF13A | 4.21e-03 | 1228 | 233 | 19 | EFO_0004713 |
| Disease | sleep measurement | 4.44e-03 | 135 | 233 | 5 | EFO_0004870 | |
| Disease | red blood cell density measurement | ITGA1 ADGRV1 ITIH3 TUBB1 PTPRC PLA2G6 PRKAG2 EP400 KALRN DNAH2 CRAT KIF20B TRIM33 DNM3 FYN | 4.51e-03 | 880 | 233 | 15 | EFO_0007978 |
| Disease | autoimmune hepatitis (is_implicated_in) | 4.57e-03 | 13 | 233 | 2 | DOID:2048 (is_implicated_in) | |
| Disease | cholangiocarcinoma (biomarker_via_orthology) | 4.57e-03 | 13 | 233 | 2 | DOID:4947 (biomarker_via_orthology) | |
| Disease | free cholesterol measurement, low density lipoprotein cholesterol measurement | 4.73e-03 | 137 | 233 | 5 | EFO_0004611, EFO_0008591 | |
| Disease | cystatin C measurement | 4.90e-03 | 402 | 233 | 9 | EFO_0004617 | |
| Disease | Neoplastic Cell Transformation | 5.02e-03 | 139 | 233 | 5 | C0007621 | |
| Disease | obsolete_red blood cell distribution width | MAG HEMGN PTK2 PRRC2C CNTN5 VPS13A PLA2G6 PRKAG2 SEC23B DNM2 TRIM15 EP400 NRF1 KALRN BZW2 ASAH2 HECTD4 CRAT TRIM33 SMARCA2 | 5.26e-03 | 1347 | 233 | 20 | EFO_0005192 |
| Disease | chromosome 22q11.2 deletion syndrome, distal (implicated_via_orthology) | 5.31e-03 | 14 | 233 | 2 | DOID:0060413 (implicated_via_orthology) | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 5.31e-03 | 14 | 233 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | superior frontal gyrus grey matter volume measurement | 5.31e-03 | 14 | 233 | 2 | EFO_0006516 | |
| Disease | neuronal ceroid lipofuscinosis (implicated_via_orthology) | 5.31e-03 | 14 | 233 | 2 | DOID:14503 (implicated_via_orthology) | |
| Disease | rostral middle frontal gyrus volume measurement | 5.31e-03 | 14 | 233 | 2 | EFO_0010328 | |
| Disease | hydroxy-leucine measurement | 5.40e-03 | 45 | 233 | 3 | EFO_0005276 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 5.99e-03 | 145 | 233 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | lateral ventricle volume change measurement | 6.09e-03 | 15 | 233 | 2 | EFO_0021502 | |
| Disease | N-acetylmethionine measurement | 6.09e-03 | 15 | 233 | 2 | EFO_0021427 | |
| Disease | arm span | 6.09e-03 | 15 | 233 | 2 | EFO_0005108 | |
| Disease | RASopathy | 6.09e-03 | 15 | 233 | 2 | cv:C5555857 | |
| Disease | Celiac Disease | 6.10e-03 | 47 | 233 | 3 | C0007570 | |
| Disease | osteoarthritis, hip | 6.16e-03 | 92 | 233 | 4 | EFO_1000786 | |
| Disease | DNA methylation | DCHS2 ABCA13 GRHL1 ALMS1 AHR PCDH10 ANKRD50 ATP9A MYZAP SMARCA2 FYN EPHA3 | 6.24e-03 | 656 | 233 | 12 | GO_0006306 |
| Disease | albuminuria | 6.64e-03 | 94 | 233 | 4 | EFO_0004285 | |
| Disease | cholesteryl ester measurement, intermediate density lipoprotein measurement | 6.64e-03 | 94 | 233 | 4 | EFO_0008595, EFO_0010351 | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 6.85e-03 | 49 | 233 | 3 | EFO_0022256 | |
| Disease | myocardial infarction | 6.93e-03 | 350 | 233 | 8 | EFO_0000612 | |
| Disease | coffee consumption, cups of coffee per day measurement | 6.93e-03 | 16 | 233 | 2 | EFO_0004330, EFO_0006782 | |
| Disease | diabetic retinopathy (implicated_via_orthology) | 6.93e-03 | 16 | 233 | 2 | DOID:8947 (implicated_via_orthology) | |
| Disease | pancreatic ductal carcinoma (is_implicated_in) | 6.93e-03 | 16 | 233 | 2 | DOID:3587 (is_implicated_in) | |
| Disease | Disorder of eye | 6.95e-03 | 212 | 233 | 6 | C0015397 | |
| Disease | free cholesterol in LDL measurement | 7.25e-03 | 50 | 233 | 3 | EFO_0022266 | |
| Disease | Liver carcinoma | 7.37e-03 | 507 | 233 | 10 | C2239176 | |
| Disease | low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 7.48e-03 | 153 | 233 | 5 | EFO_0004611, EFO_0020944 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LEAFYSIFTTEQQDH | 281 | P23470 | |
| TIQDYLGFQQSDVIH | 141 | P35869 | |
| LGFQQSDVIHQSVYE | 146 | P35869 | |
| LYITQHVNNSFSTDV | 256 | Q5NDL2 | |
| SQIYAQDENATHTQL | 2446 | Q96L91 | |
| YENHNISITNATVED | 156 | P12319 | |
| ANEDHETIRNYAQVF | 101 | Q9Y6E2 | |
| TYNNLDITVTQALQH | 486 | Q9UGJ0 | |
| DITVTQALQHRSQYF | 491 | Q9UGJ0 | |
| NLQAVIAHQDSYVET | 1001 | Q6ZSZ5 | |
| FLSESSVQHVVYDQQ | 471 | Q8NDM7 | |
| SVQHVVYDQQGIFLL | 476 | Q8NDM7 | |
| SQFSYQHAIEESVVL | 136 | O15372 | |
| NVDVSNTIYNNEVLH | 1216 | Q9BXX2 | |
| QLAFNYQELEHLQTV | 736 | Q58F21 | |
| QHEVFNVVNIVDSFY | 231 | O43506 | |
| HNIQNYENTTVFFIS | 1066 | Q9H7F0 | |
| VDNLNLNFYEGHITS | 1361 | Q86UK0 | |
| AVYQVTVLHLLSENF | 361 | Q5MAI5 | |
| QNQTHQTFLTVEKYE | 71 | P0C7U1 | |
| LLAHTNYTFEIEAVN | 431 | P54756 | |
| HVSLFVYAQNLEAQV | 2991 | Q8WXG9 | |
| YQQEFADSHQTEETL | 726 | Q8TCU4 | |
| THQQYEELEALFSQT | 86 | A6NJG6 | |
| LHSNLATAINEYNEI | 431 | A2A2Z9 | |
| NVDVSSTIYNNEVLH | 1236 | Q9BXX3 | |
| AHQLAIDTYQEFISS | 46 | Q14406 | |
| NNYIQVRVHSEVASL | 366 | Q9Y305 | |
| KHYSINQTTLEQVFI | 5016 | Q86UQ4 | |
| THITVVHNYQFFELD | 201 | P43155 | |
| SYAAVNHISQLSEEQ | 606 | Q5T2E6 | |
| SSQEIQQFAALLHEY | 311 | Q9BSQ5 | |
| QVLIAYHADVNAADN | 996 | Q9ULJ7 | |
| SHAYSVTGVEEVNFQ | 261 | A6NHC0 | |
| VFQSSHYTVNVNEDR | 711 | Q9HCU4 | |
| NVVHQLSVTLEDLYN | 106 | P31689 | |
| LTVYLSNNEQHFTEV | 6 | Q13625 | |
| AHVYQNENEVGVAIQ | 46 | P15121 | |
| VFYRQEGHSNSQVIE | 1011 | O94779 | |
| NTKSFEDIHQYREQI | 86 | P01112 | |
| VSNNHVLIYVEQVTN | 1416 | P20742 | |
| AEEQEYISNHLSFDQ | 191 | Q6ZP01 | |
| VQAFLQTYSHEVSLT | 746 | Q9Y5G6 | |
| AEEISSDVAQYINFH | 306 | Q6ZTQ3 | |
| NADLFQAITDHYIQV | 261 | Q32P28 | |
| VQAFLQTYSHEVSLT | 746 | O60330 | |
| NDNAPVFDQTSYVVH | 446 | Q9Y5F9 | |
| VFDQTSYVVHVAENN | 451 | Q9Y5F9 | |
| TREQLYQAIFHAVDQ | 121 | Q9GZU1 | |
| YFVVVNHSQSQDTVT | 171 | Q14207 | |
| AVNFSYSDNAVISEH | 971 | Q8N7Z5 | |
| VHQTVSDVRGNFYQE | 136 | Q8NFP4 | |
| VFNDQSASDHIVQFL | 121 | Q96DC9 | |
| NTANHNLEQVEYVFL | 121 | O60840 | |
| NTYSQTALDIVHQFT | 251 | Q8WXD9 | |
| ELTQNVVAFDVYNHR | 331 | Q8N239 | |
| FTQADLTSRNVQYVH | 2261 | Q86XX4 | |
| QLLSYFDQHQVTSQI | 791 | Q86YW9 | |
| QYTFSEHSVLDIVNT | 126 | P20916 | |
| ITDFNNIRYEVSHEN | 141 | Q2M2H8 | |
| FAHYVVTSQVVNTAN | 66 | P19827 | |
| DHDATQQLQGFYSQV | 461 | P19827 | |
| QTVYEAFVQQHQAEK | 986 | Q9ULD2 | |
| QSVDYSNNVHEVRIA | 111 | Q9GZR5 | |
| IINFEYVTDNENAAT | 126 | Q9NS40 | |
| LQLVNATTEYAEFLH | 71 | Q05193 | |
| QNQTHQTFLTVEKYE | 686 | Q9NR71 | |
| QFEQIVAVYHSASKQ | 331 | Q16206 | |
| FRTTYVNANEEVVSH | 471 | Q12809 | |
| TINVHDVETQFNQYK | 1111 | P15941 | |
| FDHYSSSVINVNTNI | 351 | Q5BJE1 | |
| HSDYEHVQNVIENIF | 5671 | Q5CZC0 | |
| IQVSYINTNHEDFIG | 481 | Q9UQ16 | |
| HTQYTFEIQAVNGVT | 401 | P29323 | |
| VIQAYEIASFQVAAH | 326 | Q6X9E4 | |
| AYSESHQIRVSQQDF | 246 | Q5NUL3 | |
| FDNIYLHVQISNESA | 106 | Q9GZZ1 | |
| EHITSEYTLQNQDTF | 206 | O15534 | |
| LIFAVTQEQVHLYEN | 326 | P18564 | |
| INDNAPVFHQASYVV | 441 | Q9Y5G3 | |
| INIYHNTASNTFRVV | 36 | Q9UI08 | |
| VQDATFVYATLQTAH | 421 | Q5XG92 | |
| NETHFLNNTLLEYVD | 1006 | O94915 | |
| YHVNFSQAISQDVNL | 301 | Q9Y4A8 | |
| IQSNYDIAIAELHVQ | 936 | Q96Q89 | |
| FEVIQQGQDLHQYIT | 826 | O60229 | |
| QGQDLHQYITEVQAS | 831 | O60229 | |
| AQQVQQVHVATYTEH | 21 | Q16656 | |
| ANTQDTVRFVHVYSN | 411 | Q9Y2G8 | |
| HVYSNRQQEFADTLL | 421 | Q9Y2G8 | |
| IQHNNSTQTDIFYTD | 836 | Q8TDM6 | |
| NLEDQAHLATYTEFV | 616 | Q86TG7 | |
| QLFQEYDNHIKSSVV | 236 | Q9Y6K9 | |
| QAAQSEAKVVSQYHE | 346 | Q16891 | |
| EHNVFQNKIHVSYQE | 386 | Q86UP2 | |
| EYSVEQAQQVLHQSV | 491 | Q8NA19 | |
| FVYNSVSTINHQALE | 141 | Q96PP9 | |
| TEFIEQYTGHVQQQD | 56 | Q9UGJ1 | |
| SIQHNTRSNVIFYIV | 86 | Q68CQ7 | |
| VQSHIFSIYTQQSQD | 421 | O75110 | |
| NTEAHVENITFYQNQ | 116 | Q9ULI3 | |
| TVEDHNTQYFNFVEL | 121 | Q8NAT1 | |
| VFHQASYTVHVAENN | 451 | Q9Y5G1 | |
| THIILDNADVLSQYQ | 46 | Q9UKK3 | |
| VAQVIVFQTYTNKSH | 636 | Q9UKK3 | |
| VFSQLHYTVQEEQEH | 16 | Q9P2E7 | |
| YELDTIQQHQAFLSS | 671 | Q9BZ72 | |
| LQSLINFQYQEEHAE | 921 | Q9Y4D8 | |
| IVQYGENVTHEFNLN | 211 | P56199 | |
| IEQSYINTNHEDFIG | 481 | P50570 | |
| YIFNSLDDVAHVNTV | 466 | Q9H422 | |
| IVVQFNSHVVGAYQN | 521 | Q9P0J1 | |
| TEVLEYNNNFHVLSS | 286 | Q8NFU5 | |
| NFSEYQEIAVQNHSS | 146 | Q9BXL5 | |
| NSQTETHNVFYVQEA | 266 | P78552 | |
| QNQIHVQYSTDFGVS | 2771 | P78509 | |
| AQVEEFLAQHGSEYQ | 331 | Q02809 | |
| QYSIQVQVEDLTHFR | 331 | Q96CB9 | |
| VSESQLYNAHVIQVF | 2251 | Q6V1P9 | |
| LYNAHVIQVFATDLD | 2256 | Q6V1P9 | |
| QEVTYAQLDHCIFTQ | 296 | Q99706 | |
| EEATFQQIYSQHVAL | 791 | Q13415 | |
| YSHLEEFEQIQSQTF | 536 | Q9P2D7 | |
| HEVRLSSKQFQNYIE | 926 | A4FU69 | |
| IETQQAFYQVSLLDH | 176 | Q9NQ11 | |
| QITHNKEFAYEQEVA | 451 | Q01638 | |
| YDQNFETQIVASDHT | 1526 | Q9Y2F5 | |
| NIIEHYSNEDTFILN | 596 | Q6ISB3 | |
| VKHYSNEDTFQLQIE | 591 | Q9NZI5 | |
| ELQQVTSDYHGLAQQ | 531 | Q8NCX0 | |
| LSSHFQELSIYQDQE | 126 | P55265 | |
| ISHLQVSNQEIQTYA | 221 | Q96JJ3 | |
| PVTAYQHSFQVENQE | 281 | Q9NZD1 | |
| FETLQQLVQHYSERA | 221 | P06241 | |
| VDITATNHTNEIQDY | 46 | P35754 | |
| QNIQVAEEHYSLFLQ | 766 | Q8NCU4 | |
| SHSFVVNILAQALYE | 461 | Q14534 | |
| NETIVENLLANVYHQ | 101 | P01574 | |
| QLARSFHVQEDYDQA | 311 | Q6PD62 | |
| AIADGYQQQHSQVFV | 1261 | O75976 | |
| AHTNYTFEIDAVNGV | 401 | P29320 | |
| HVEQTVHSQETAANY | 811 | Q6IMN6 | |
| LQTVHAEYSRFVNQI | 316 | Q7Z7F0 | |
| QNQEQFEEHFVASSV | 46 | Q96L11 | |
| IAAVAVVYNRQQHSQ | 706 | Q6ZMW3 | |
| ASHDNFVDIYNVLTS | 1101 | Q6ZMW3 | |
| DVQIHAERFINYNQT | 901 | Q8N766 | |
| YSHVFQISTDLQDLV | 766 | Q9BXX0 | |
| QVYAANEDHNSQFID | 1036 | Q5T890 | |
| VQEVAYIHSNQNVIG | 1126 | Q5T890 | |
| NQVAAALTLQSSHEY | 921 | P54198 | |
| TDYQVNIQIIHTDSN | 416 | Q9BX70 | |
| QQLFSENSENISYHL | 766 | Q9C0D2 | |
| IHVANNTIQVEEVQY | 2236 | Q9UGM3 | |
| SLAVQQLSRQDHYDF | 1961 | Q9P225 | |
| DEYFVHNNVTSIQGI | 421 | Q9UHW9 | |
| NFVETEQIVHYNGSK | 236 | Q9NTJ5 | |
| NGNVANYVETEQLIH | 301 | Q9Y2H2 | |
| SALQLEAITYAAQQH | 291 | A3KN83 | |
| FQTQEGEQIYQRVHS | 211 | Q8TEW6 | |
| QELYINHNQISTISA | 146 | Q6UXK5 | |
| DYEVCLTVSNIHQQT | 591 | Q6UXK5 | |
| VNHVDFSQNVAVANY | 136 | Q99574 | |
| DFDVSNISIYLNHVL | 6 | Q8NGV5 | |
| SHAVFNIIITQTLYD | 221 | Q9H1H9 | |
| AEHVQQFYNLLTASI | 431 | Q92570 | |
| KQHLTDFVIEYNTEN | 251 | Q8N807 | |
| HSSLYFVNASLQEVV | 21 | O60469 | |
| YDEQENHSLIGVANV | 791 | Q9NQT8 | |
| QFQVQHYVSQSLVTL | 256 | A8MW99 | |
| AEHTQAQVSFLLEYL | 1671 | Q86VV8 | |
| YVVDNGQSVHFQTIF | 406 | P54136 | |
| TLENFYSNLIAQHEE | 26 | Q15208 | |
| YVHFAATQVQNRIKE | 336 | Q9UPN9 | |
| YGQATELAEHQAIDQ | 311 | Q96M34 | |
| IASNFLHAYIVVQVE | 376 | Q684P5 | |
| DEVNSELVNIYTFNH | 41 | Q8NBJ9 | |
| ELVNIYTFNHTVTRN | 46 | Q8NBJ9 | |
| NIETIINTFHQYSVK | 11 | P06702 | |
| VSHINDLSDFYVQLI | 1311 | O60522 | |
| YLTVDQLVSFLNEHQ | 236 | Q15147 | |
| HNAQTFNLEGSQIYE | 1476 | P51531 | |
| ALQYQHATVRVLTQF | 571 | Q8N3T6 | |
| HSDQQVLAYTVREQQ | 341 | Q6ZMQ8 | |
| NEDASVFVTEQYNDH | 676 | Q6T4R5 | |
| TVFSNELHYVANELN | 416 | Q969Y0 | |
| NYHNEVDIVGNIQAT | 131 | Q8NFW8 | |
| EEQENVYFLQNAIHS | 806 | Q8IVG5 | |
| ENAILDLTQNTYQHF | 481 | Q06033 | |
| NFYDTVGTIQLINDH | 171 | P29622 | |
| NYRFAHTNVESLVNE | 181 | P30101 | |
| THLADFTQVQTIQYS | 291 | Q05397 | |
| QEQNFESHYNEILET | 251 | A1L4K1 | |
| QEEHQELQLYSLASF | 206 | Q6ZW05 | |
| QEADSQVDLVRQHFY | 161 | Q9UNA1 | |
| EQITAAYSVEHNQLE | 841 | Q9Y520 | |
| AENNIHDLVSEYQQF | 411 | Q9H4B7 | |
| LEADALVNFHQYSSQ | 76 | O60733 | |
| AIFTIHYTQAILENN | 226 | Q9P2P6 | |
| EAHLATEYVQHIQQA | 1221 | Q6P1J6 | |
| HDAENQTVVKYINFE | 411 | Q12769 | |
| QTVVKYINFEHNVAG | 416 | Q12769 | |
| LQYSVQVAHDNTVVA | 126 | Q13018 | |
| KAQLVSITDQYHQSF | 1146 | Q13018 | |
| VNAVIDHYTSQIVFN | 341 | Q8IY50 | |
| QFYHTTIESVDFQKN | 136 | Q96P63 | |
| TSTLGIYFEVVNQHN | 456 | Q15437 | |
| AVHYAVNSENLSVVA | 141 | A7E2S9 | |
| KVTVATNQYEQAIFH | 206 | Q70Z44 | |
| SAHVYNNEEQVGLAI | 51 | P52895 | |
| DYDILSLSNIQQHSV | 41 | P78536 | |
| HLQTVTNYFIVNLAV | 126 | P25100 | |
| TEFFQNISSEHQTQL | 316 | Q9NPF2 | |
| SHFYVSDEAQNNGLI | 456 | Q14CN2 | |
| SEETVLQALHQYNLQ | 71 | Q8WW14 | |
| TETQFTAVTAYQNHR | 221 | O75333 | |
| TEEVNQASQFHQYVQ | 156 | A4UGR9 | |
| QASQFHQYVQETVID | 161 | A4UGR9 | |
| IDDVSSLQHYVQNNS | 131 | Q96PE6 | |
| GHTLLEDYQIVDNSQ | 621 | Q8N0X7 | |
| QVYVALSSFQNHVNL | 476 | Q96CK0 | |
| QVIQLEDGSAAYVQH | 76 | P52747 | |
| NYQFHTTSDLQSEVI | 2831 | Q96RL7 | |
| IVHEIYNGENAQDQF | 31 | P17152 | |
| LNSTEHFQASIQDYT | 821 | Q7RTX1 | |
| AQAQTYHVSFETLAE | 221 | Q6ZVD8 | |
| QVLEQALADYAQTIH | 1631 | O15020 | |
| VRFQVHYVTSTDVQF | 266 | O95210 | |
| AEANQYTFHLEATEN | 86 | Q2QD12 | |
| HLVAFYQEQSQLQSE | 726 | Q8NDV3 | |
| EQSQAEIYHNRFDAV | 106 | Q9NPL8 | |
| LQDLSIFITNVTYNH | 101 | Q07699 | |
| YEAGQVTLHNAQTQE | 421 | Q9C019 | |
| AADQAYEHFIIQVQE | 1096 | P24821 | |
| DNAYEHFVIQVQEVN | 1371 | P24821 | |
| YFEAVQLSSQQRIHV | 1171 | Q8IWV7 | |
| NEVVTQQYLFDRLAH | 1041 | O43847 | |
| VEFQKLNVSNYSHVS | 181 | P48066 | |
| HQTTEVNYGQFQDTA | 226 | A8MV23 | |
| VHNQFSLVSDEDYLN | 1271 | Q709C8 | |
| HFESLSIILYNNDIN | 1941 | Q709C8 | |
| ITHETENEFVYRGNN | 901 | Q86WI1 | |
| NALATDNHVAYSQVF | 1031 | Q9NYK1 | |
| DLYNNSVIVQAVRDH | 486 | P49754 | |
| HLYVNVSELSLVNFE | 256 | P48023 | |
| IQTLEHNFEYSICQE | 211 | Q06730 | |
| DETYSDINQEHVNLF | 876 | Q9H582 | |
| NYHSEILAINQVFDI | 271 | Q6PF06 | |
| QELTRAHVESFNYAV | 36 | Q9H9Y6 | |
| HLVTSDNQVQYIISQ | 1216 | Q9H4Z2 | |
| HQALVEYNQFGETEV | 906 | P08575 | |
| LYVTNVKAQHEFTEF | 581 | Q9UBN4 | |
| NQESAVSQQAVYHSE | 1301 | Q9BVV6 | |
| VSQNEDLFRHQYIQT | 226 | B1APH4 | |
| QISKEHFTVYQQEIS | 111 | Q9P1Q0 | |
| NIYVHDLLTFQQITT | 96 | Q96JC1 | |
| DVTLQQLESHSFYNL | 86 | P16473 | |
| NETNANYISIVDEHE | 111 | Q9Y3Q0 | |
| QLTQELSVSHAQQEY | 131 | P0CAP1 |